Home/Filings/4/0001628280-23-038374
4//SEC Filing

Xian Ming 4

Accession 0001628280-23-038374

CIK 0000910329other

Filed

Nov 8, 7:00 PM ET

Accepted

Nov 9, 8:19 PM ET

Size

6.0 KB

Accession

0001628280-23-038374

Insider Transaction Report

Form 4
Period: 2023-11-07
Xian Ming
Director
Transactions
  • Purchase

    Restricted Stock Units (cash settled)

    2023-11-07$68.89/sh+48.441$3,3374,812.918 total
    Common Stock (48.441 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit (cash settled) is the economic equivalent of one share of Medifast's common stock. Restricted stock units become payable, in cash, following termination of the Reporting Person's service as a director.
  • [F2]Accrual of dividend equivalents in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The dividend equivalents accrued when and as dividends were paid on Medifast common stock.

Issuer

MEDIFAST INC

CIK 0000910329

Entity typeother

Related Parties

1
  • filerCIK 0001743879

Filing Metadata

Form type
4
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 8:19 PM ET
Size
6.0 KB